Evidence map›Paper›PMID 42573660›Full record

ArticleEuropean radiology experimental2026

Impact of structured reporting on interpretability of PSMA PET/CT in prostate cancer staging-towards standardised clinical implementation.

Gloria Biechele, Moritz Schnitzer, Romy Göbel, Niels Bauer, Sarah Takayama Fouladgar, Felix Herr, Mirlind Zaganjori, Adrien Holzgreve, Konrad Klimek, Rudolf Werner and 4 more

Abstract read
In one paragraph

Article in European radiology experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Gloria BiecheleDepartment of Radiology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany. gloria.biechele@med.uni-muenchen.de.ORCID http://orcid.org/0009-0008-5161-9571
Moritz SchnitzerDepartment of Radiology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Romy GöbelDepartment of Radiology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Niels BauerDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Sarah Takayama FouladgarDepartment of Urology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Felix HerrDepartment of Radiology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Mirlind ZaganjoriDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Adrien HolzgreveDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Konrad KlimekDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Rudolf WernerDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Clemens CyranDepartment of Radiology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Jens RickeDepartment of Radiology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Johannes RübenthalerDepartment of Radiology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Thomas GeyerDepartment of Radiology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study assessed the impact of structured reporting (SR) compared with conventional free-text reporting (FTR) on report quality for PSMA PET/CT for diagnosis and staging of prostate cancer (PC) using a dedicated template. MATERIALS AND

methodsFifty consecutive patients were included. Original clinical FTRs were compared with SRs retrospectively generated for the same examinations using template-based online software featuring clickable decision trees. Two readers specialised in urology and radioligand therapy independently assessed reports with regard to completeness, ease of information extraction, linguistic and overall report quality.

resultsFTR achieved higher scores for overall report quality compared with SR (mean 5.46 versus 4.71; p < 0.0001) and was associated with fewer missing key features (present in 36% of FTR versus 54% of SR; p = 0.005). Information was rated sufficient to guide decision-making regarding surgery versus conservative therapy in 91% of FTR compared to 76% of SR (p = 0.018). Information extraction was rated easy in 69% of FTR compared to 50% of SRs (p = 0.007). FTR received higher scores for linguistic quality (mean 5.69 versus 5.09; p < 0.001). The key clinical questions were answered equally between reporting formats (p = 0.68).

conclusionIn PSMA PET/CT reporting, FTR consistently achieved higher ratings than template-based SR, with respect to overall report quality, clinical usefulness for management decisions, information retrieval, and linguistic quality. These findings underline that the performance of SR strongly depends on template design, implementation workflow, and local reporting expertise, and that SR tools require careful, indication-specific validation. KEY POINTS: Question Does SR improve the quality, completeness, interpretability, and clinical usefulness of PSMA PET/CT reports for PC staging compared with FTR? Findings FTR were rated superior to SR regarding clinical decision-making, completeness, report quality, and information retrieval. Relevance statement In PSMA PET/CT, report format directly affects the usability of imaging findings for therapeutic decision-making. The effectiveness of SR appears dependent on local reporting expertise and clinical context, underscoring the need for prospective, indication-specific validation before routine clinical implementation.

Indexed as

Positron Emission Tomography Computed TomographyProstatic NeoplasmsAgedHumansMaleMiddle AgedNeoplasm StagingRetrospective StudiesMedical records systems (computerised)Neoplasm stagingPositron-emission tomography computed tomographyProstatic neoplasms

Identifiers

PMID42573660
PMCPMC13457528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.